Canadian Nano Pharmaceutical Technology (CNANO)
Vancouver, CA · 1 known investors
novoLUX develops science-based skincare using LNP3, a patented triple-layer lipid nanoparticle technology that delivers peptides, exosomes, and PDRN with sustained release. The products target specific skin concerns such as acne-prone skin, post-procedure repair, dryness, hyperpigmentation, fine lines, and radiance.
BiotechConsumerWellness & Fitness
Investors · 1
Frequently asked questions
- What does Canadian Nano Pharmaceutical Technology (CNANO) do?
- novoLUX develops science-based skincare using LNP3, a patented triple-layer lipid nanoparticle technology that delivers peptides, exosomes, and PDRN with sustained release. The products target specific skin concerns such as acne-prone skin, post-procedure repair, dryness, hyperpigmentation, fine lines, and radiance.
- Who are Canadian Nano Pharmaceutical Technology (CNANO)'s investors?
- Canadian Nano Pharmaceutical Technology (CNANO)'s investors include Innovation UBC.
- Where is Canadian Nano Pharmaceutical Technology (CNANO) headquartered?
- Canadian Nano Pharmaceutical Technology (CNANO) is headquartered in Vancouver, CA.